Replies to post #6741 on Nutra Pharma Corp (NPHC)

[Cobraman]

One can not compare public companies with FDA approved drugs with a product that you admit has an up hill battle to be accepted.

Sometimes one is too close to the forest to see the trees when it comes to DD. The only thing that matters here is revenues. Lets see Schein make an impact. IMO they are taking a low profit margin high risk bet. From their POV their territorial salespeople are already there.